Pricing Log in Create free account
Friday 6 November 2026 Export VCEL’s income statement to Excel — free account

Vericel Corporation

VCEL Healthcare Biotechnology

Vericel Corporation’s revenue for fiscal 2025 (year ended December 2025) was $276.3 million, up 16.5% from fiscal 2024.

Revenue
+26.5%
EPS
+180.0%
Free cash flow
−19.4%

Quarter to September 2026, against a year earlier

54.08 2.30 +4.44%
Market cap
$2.7B
P/E
77.8×
Fwd P/E
72.9×
Dividend yield
—
F-score
7/9
Altman Z
8.21
Beneish M
−2.53
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Vericel Corporation (VCEL) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, Vericel Corporation (VCEL) trades at a EV/Sales of 7.6×. Over the past ten years it has ranged from 0.1× (January 2015) to 23.1× (June 2021); the current reading is higher than 63% of that period. That is below the Biotechnology industry median of 9.0× and above the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 6.1× (43.51%)
FY2024 10.8× 38.21%
FY2023 7.8× 19.19%
FY2022 6.6× (40.91%)
FY2021 11.1× 3.42%
FY2020 10.8× 77.26%
FY2019 6.1× (12.98%)
FY2018 7.0× 138.53%
FY2017 2.9× 194.39%
FY2016 1.0× 8.65%

Quarterly newest first

Period EV/Sales Change
Sep 2026 5.9× (15.53%)
Jun 2026 6.9× 34.75%
Mar 2026 5.2× (15.88%)
Dec 2025 6.1× 7.77%
43 more quarters

Against its own ten years

Low 0.1× High 23.1×
Ten-year median 6.7×
Current reading's percentile 60

EV/Sales against peers

Company EV/Sales
PHVS Pharvaris N.V. compare n/m
VERA Vera Therapeutics, Inc. compare n/m
BHVN Biohaven Ltd. compare 2.2×
AUPH Aurinia Pharmaceuticals Inc compare 5.3×
ADMA ADMA Biologics Inc compare 5.8×
VCEL Vericel Corporation 7.6×
PVLA Palvella Therapeutics, Inc. compare 48.1×
IMNM Immunome, Inc. compare 121×
CLDX Celldex Therapeutics, Inc. compare 1,691×
Biotechnology industry median 9.0×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on VCEL